In the Media
Active Motif team Dr. Rwik Sen, Zachary Verlander, and Alisa Cummings publish an insightful review “Advances in understanding epigenetic impacts on dendritic cell regulation and function.” Clinical and Translational Discovery, June 21, 2022.
Active Motif scientist Dr. Benjamin Delatte publishes work on a novel method for analysis of DNA Methylation: “Anchor-based bisulfite sequencing determines genome-wide DNA methylation.” Communications Biology, June 16, 2022.
Active Motif Announces New Report Describing Advancements in Generation and Characterization of Their Recombinant Human COVID-19 Antibodies with Qualities that Make Them Ideal for Use in Diagnostics and Therapeutics
Active Motif launches a portfolio of recombinant COVID-19 antibodies; the first full human antibodies derived from patients infected with the 2019 Coronavirus, now available for research and commercial use.